Adult Therapeutics Handbook: Content update July 2017
The Therapeutics Handbook content has now been updated and includes the following main changes:
Guidelines which recommend aztreonam have been updated to include an additional therapeutic choice, temocillin. This change has been necessary due to the ongoing critical shortage of aztreonam. Aztreonam use is being prioritised for patients with Cystic Fibrosis. Please note, previous advice to review choice of gentamicin in frail elderly patients or patients with reduced renal function has been reviewed and amended to give more specific advice based on eGFR.
Endocrine Systems sections:
Within the Management of Hypoglycaemia, the volume of Lucozade® recommended to treat mild hypoglycaemia has changed in response to the introduction of a new Lucozade® formulation.
If you have not already done so please update your App on receipt of the notification. If you are not able to update your app then please refer to the GGC Medicines desktop site here as the website content is always live with the most up to date information. For more information or assistance with any aspect of the GGC Medicines app or Therapeutics handbook please contact firstname.lastname@example.org.